Current evidences in the first-line treatment of metastatic non-clear cell renal cell carcinoma

被引:0
|
作者
Inokuchi, Junichi [1 ]
Goto, Shunsuke [1 ]
Monji, Keisuke [1 ]
Eto, Masatoshi [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka, Japan
关键词
D O I
10.1016/j.annonc.2023.09.052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SY13-2
引用
收藏
页码:S1362 / S1362
页数:1
相关论文
共 50 条
  • [1] Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
    Atkins, Michael B.
    Tannir, Nizar M.
    [J]. CANCER TREATMENT REVIEWS, 2018, 70 : 127 - 137
  • [2] Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
    Xu K.Y.
    Wu S.
    [J]. Biomarker Research, 3 (1)
  • [3] Metastatic non-clear cell renal cell carcinoma: current therapeutic options
    Schrader, Andres J.
    Olbert, Peter J.
    Hegele, Axel
    Varga, Zoltan
    Hofmann, Rainer
    [J]. BJU INTERNATIONAL, 2008, 101 (11) : 1343 - 1345
  • [4] Current treatment approach to non-clear cell renal carcinoma
    Timofeev, I. V.
    [J]. ONKOUROLOGIYA, 2015, 11 (04): : 24 - 33
  • [5] Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
    Brown, Jason R.
    Calaway, Adam
    Castle, Erik
    Garcia, Jorge
    Barata, Pedro C.
    [J]. KIDNEY CANCER, 2022, 6 (01) : 53 - 68
  • [6] Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies
    Sankin, Alexander
    Hakimi, A. Ari
    Hsieh, James J.
    Molina, Ana M.
    [J]. FRONTIERS IN ONCOLOGY, 2015, 5
  • [7] Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
    Bonadio, Renata Colombo
    Velho, Pedro Isaacsson
    Marta, Guilherme Nader
    Narda, Mirella
    La Souza, Manoel Carlos
    Muniz, David Q. B.
    Bezerra, Regis O. F.
    Bispo, Raisa K. A.
    Faraj, Sheila F.
    Bastos, Diogo A.
    Dzik, Carlos
    [J]. ECANCERMEDICALSCIENCE, 2019, 13
  • [8] Effectiveness of first-line therapy in patients with advanced non-clear renal cell carcinoma (nccRCC).
    Laramee, Sophie
    Ghosh, Sunita
    Kollmannsberger, Christian K.
    Hansen, Aaron Richard
    Wood, Lori
    Soulieres, Denis
    Canil, Christina M.
    Saleh, Ramy
    Castonguay, Vincent
    Bjarnason, Georg A.
    Basappa, Naveen S.
    Breau, Rodney H.
    Heng, Daniel Yick Chin
    Pouliot, Frederic
    Kapoor, Anil
    Lalani, Aly-Khan A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [9] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Yu-Wei Chen
    Brian I. Rini
    [J]. Current Oncology Reports, 2022, 24 : 695 - 702
  • [10] Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma
    Chen, Yu-Wei
    Rini, Brian, I
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (06) : 695 - 702